| Ident. | Authors (with country if any) | Title |
|---|
| 000144 (1990) |
M. Jhanwar-Uniyal [États-Unis] ; J. A. Menendez [Australie] ; D. M. Atrens [Australie] ; B. Beck [France] ; A. Burlet [France] ; C. Burlet [France] ; S. F. Leibowitz [États-Unis] | Neuropeptide Y in Relation to Metabolism and Nutritional State |
| 000145 (1998) |
J. F Hocquette [France] ; I. Ortigues-Marty [France] ; D. Pethick [Australie] ; P. Herpin [France] ; X. Fernandez [France] | Nutritional and hormonal regulation of energy metabolism in skeletal muscles of meat-producing animals |
| 000293 (2005) |
H. Toplak [Autriche] ; O. Ziegler [France] ; U. Keller [Suisse] ; A. Hamann [Allemagne] ; C. Godin [Canada] ; G. Wittert [Australie] ; M. Zanella [Brésil] ; S. Zú Iga-Guajardo [Mexique] ; L. Van Gaal [Belgique] | X‐PERT: weight reduction with orlistat in obese subjects receiving a mildly or moderately reduced‐energy diet. Early response to treatment predicts weight maintenance |
| 000385 (2003) |
J. P. Braun [France] ; H. P. Lefebvre [France] ; A. D. J. Watson [Australie] | Creatinine in the Dog: A Review |
| 000618 (1997) |
Jr Buddle ; Ar Mercy ; Sz Skirrow ; F. Madec [France] ; Rr Nicholls | Epidemiological studies of pig diseases: 1. Use of French protocols for risk factor assessment to predict the health status of Australian herds |
| 000685 (1983) |
D. M. Atrens [Australie] ; P. Marfaing-Jallat [France] ; J. Le Magnen [France] | Ethanol prefernce following hypothalamic stimulation: Relation to stimulation parameters and energy balance |
| 000777 (1990) |
M. Van Den Buuse [France] ; G. A. Head [Australie] ; P. I. Korner | Involvement of forebrain noradrenergic projections in the cardiovascular effects of clonidine, α-methyldopa and 6-hydroxydopamine in conscious rabbits |
| 000924 (2012) |
S. Van Dieren [Australie, Pays-Bas] ; S. Czernichow [France] ; J. Chalmers [Australie] ; A. P. Kengne [Australie, Pays-Bas, Afrique du Sud] ; B. E. De Galan [Pays-Bas] ; N. Poulter [Royaume-Uni] ; M. Woodward [Australie] ; J. W. J. Beulens [Pays-Bas] ; D. E. Grobbee [Pays-Bas] ; Y. T. Van Der Schouw [Pays-Bas] ; S. Zoungas [Australie] | Weight changes and their predictors amongst 11 140 patients with type 2 diabetes in the ADVANCE trial |
| 000927 (2005) |
I. Pelc [Belgique] ; C. Hanak ; I. Baert ; C. Houtain ; P. Lehert [Australie] ; F. Landron [France] ; P. Verbanck | EFFECT OF COMMUNITY NURSE FOLLOW-UP WHEN TREATING ALCOHOL DEPENDENCE WITH ACAMPROSATE |
| 000B63 (2013) |
J. Yale [Canada] ; G. Bakris [États-Unis] ; B. Cariou [France] ; D. Yue [Australie] ; E. David-Neto [Brésil] ; L. Xi [États-Unis] ; K. Figueroa [États-Unis] ; E. Wajs [Belgique] ; K. Usiskin [États-Unis] ; G. Meininger [États-Unis] | Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease |
| 000C57 (1985) |
Dale M. Atrens [Australie] ; John D. Sinden [France] ; Luc Pénicaud [France] ; Michelle Devos [France] ; Jacques Le Magnen [France] | Hypothalamic modulation of energy expenditure |
| 001164 (2009) |
M. Marre [Australie] ; J. Shaw [Australie] ; M. Br Ndle [Australie] ; W. M. W. Bebakar [Australie] ; N. A. Kamaruddin [Australie] ; J. Strand [Australie] ; M. Zdravkovic [Australie] ; T. D. Le Thi [Australie] ; S. Colagiuri [Australie] | Liraglutide, a once‐daily human GLP‐1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with Type 2 diabetes (LEAD‐1 SU) |
| 001199 (2008) |
Peter T. Katzmarzyk [États-Unis, Canada] ; Louise A. Baur [Australie] ; Steven N. Blair [États-Unis] ; Estelle V. Lambert [Afrique du Sud] ; Jean-Michel Oppert [France] ; Chris Riddoch [Royaume-Uni] | International Conference on Physical Activity and Obesity in Children: Summary Statement and Recommendations |
| 001549 (2007) |
F. Bonino [Italie] ; P. Marcellin [France] ; G K K. Lau [République populaire de Chine] ; S. Hadziyannis [Grèce] ; R. Jin [République populaire de Chine] ; T. Piratvisuth [Thaïlande] ; G. Germanidis [Grèce] ; C. Yurdaydin [Turquie] ; M. Diago [Espagne] ; S. Gurel [Turquie] ; M-Y Lai [République populaire de Chine] ; M R Brunetto [Italie] ; P. Farci [Italie] ; M. Popescu [Suisse] ; P. Mccloud [Australie] | Predicting response to peginterferon α-2a, lamivudine and the two combined for HBeAg-negative chronic hepatitis B |
| 001586 (2002) |
A. R. Jones [Australie] ; C. Morin ; W. Bone [Allemagne] ; T. G. Cooper [Allemagne] | Lack of antifertility properties of novel halogenated glycolytic inhibitors and the urinary excretion and metabolism of 1,6‐dichloro‐1,6‐dideoxy‐D‐fructofuranose in the male rat |
| 001A97 (2008) |
A. M. Wolf [États-Unis] ; N. Finer [Royaume-Uni] ; A. A. Allshouse [États-Unis] ; K. B. Pendergast [États-Unis] ; B. H. Sherrill [États-Unis] ; I. Caterson [Australie] ; J. O. Hill [États-Unis] ; L. J. Aronne [États-Unis] ; H. Hauner [Allemagne] ; C. Radigue [France] ; C. Amand [France] ; J. Despres [Canada] | PROCEED: Prospective Obesity Cohort of Economic Evaluation and Determinants: baseline health and healthcare utilization of the US sample |
| 001F59 (2010) |
Badrish Soni [France, Inde, Australie] ; Nishant P. Visavadiya [Inde, États-Unis] ; Nirav Dalwadi [Inde] ; Datta Madamwar [Inde] ; Chris Winder [Australie] ; Christian Khalil [Australie] | Purified c‐phycoerythrin: safety studies in rats and protective role against permanganate‐mediated fibroblast‐DNA damage |
| 002055 (1984) |
D. M. Atrens [Australie] ; J. D. Sinden [France] ; L. Pénicaud [France] ; J. Louis-Sylvestre [France] ; J. Le Magnen [France] | The effect of electrical stimulation of the hypothalamus on continuously-monitored blood glucose levels |
| 002060 (2001) |
J. B Furness [Australie] ; H. S Koopmans [Canada] ; H. L Robbins [Australie] ; N. Clerc [France] ; J. M Tobin [Australie] ; M. J Morris [Australie] | Effects of vagal and splanchnic section on food intake, weight, serum leptin and hypothalamic neuropeptide Y in rat |
| 002152 (2002) |
Greg Collier [Australie] ; Ken Walder [Australie] ; Andrea De Silva [Australie] ; Janette Tenne-Brown [Australie] ; Andrew Sanigorski [Australie] ; David Segal [Australie] ; Lakshmi Kantham [Australie] ; Guy Augert [France] | New Approaches to Gene Discovery with Animal Models of Obesity and Diabetes |
| 002253 (2013) |
J. H Ggström [Suède] ; A. Boswood ; M. O'Grady [Canada] ; O. Jöns [Allemagne] ; S. Smith [Royaume-Uni] ; S. Swift [Royaume-Uni] ; M. Borgarelli [Italie] ; B. Gavaghan [Australie] ; J. Kresken [Allemagne] ; M. Patteson [Royaume-Uni] ; B. Blad [Suède] ; C. M. Bussadori [Italie] ; T. Glaus [Suisse] ; A. Kova Evi [Allemagne] ; M. Rapp [Suède] ; R. A. Santilli [Italie] ; A. Tidholm [Suède] ; A. Eriksson [Finlande] ; M. C. Belanger [Canada] ; M. Deinert [Allemagne] ; C. J. L. Little [Royaume-Uni] ; C. Kvart [Suède] ; A. French [Royaume-Uni] ; M. R Nn-Landbo [Danemark] ; G. Wess [Allemagne] ; A. Eggertsdottir [Norvège] ; M. Lynne O'Sullivan [Canada] ; M. Schneider [Allemagne] ; C. W. Lombard [Suisse] ; J. Dukes-Mcewan [Royaume-Uni] ; R. Willis [Royaume-Uni] ; A. Louvet [France] ; R. Difruscia [Canada] | Longitudinal Analysis of Quality of Life, Clinical, Radiographic, Echocardiographic, and Laboratory Variables in Dogs with Myxomatous Mitral Valve Disease Receiving Pimobendan or Benazepril: The QUEST Study |
